These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 365748)

  • 21. Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoic acid in staphylococcal infections.
    Oeding P; Wergeland H; Endresen C; Natås O; Aasjord P
    Scand J Infect Dis Suppl; 1983; 41():126-9. PubMed ID: 6589748
    [No Abstract]   [Full Text] [Related]  

  • 22. [Isolation of lipoteichoic acid from hemolytic Streptococcus group A type 29].
    Kudrina ES; Dmitrieva NF; Petrov GI; Savel'ev EP
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (4):93-7. PubMed ID: 7044431
    [No Abstract]   [Full Text] [Related]  

  • 23. Streptolysin S activation by lipoteichoic acid.
    Theodore TS; Calandra GB
    Infect Immun; 1981 Jul; 33(1):326-8. PubMed ID: 7021426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of nephrocalcinosis in rabbit kidneys after long-term exposure to a streptococcal teichoic acid.
    Waltersdorff RL; Fiedel BA; Jackson RW
    Infect Immun; 1977 Sep; 17(3):665-7. PubMed ID: 332635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-Alanyl-substituted glycerol lipoteichoic acid in culture fluids of Streptococcus mutans strains GS-5 and BHT.
    Levine M; Movafagh BF
    Infect Immun; 1984 Dec; 46(3):870-2. PubMed ID: 6500717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of lipoteichoic acid from Streptococcus pyogenes type 29 isolated by different methods].
    Vylegzhanina ES; Dmitrieva NF; Bitko SA; Petrov GI; Naumova IB
    Prikl Biokhim Mikrobiol; 1985; 21(6):788-93. PubMed ID: 3911202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of anti-kojibiose antibody with the lipoteichoic acids from Streptococcus faecalis and Streptococcus faecium.
    Kessler RE; Duke J; Goldstein IJ
    Infect Immun; 1984 Oct; 46(1):279-81. PubMed ID: 6434429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activation of the classical pathway of complement by a streptococcal lipoteichoic acid.
    Monefeldt K; Helgeland K; Tollefsen T
    Oral Microbiol Immunol; 1994 Apr; 9(2):70-6. PubMed ID: 8008432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a streptococcal lipoteichoic acid on complement activation in vitro.
    Monefeldt K; Tollefsen T
    J Clin Periodontol; 1993 Mar; 20(3):186-92. PubMed ID: 8450083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens.
    Brown TA; Mestecky J
    Infect Immun; 1985 Aug; 49(2):459-62. PubMed ID: 2410367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group A streptococcal adhesion. All of the theories are correct.
    Hasty DL; Courtney HS
    Adv Exp Med Biol; 1996; 408():81-94. PubMed ID: 8895780
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of a streptococcal lipoteichoic acid on host responses in mice.
    Miller GA; Urban J; Jackson RW
    Infect Immun; 1976 May; 13(5):1408-17. PubMed ID: 773834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of group A streptococcal lipoteichoic acid with bovine myelin basic protein.
    Ofek I; Whitaker JN; Campbell GL; Beachey EH
    J Infect Dis; 1979 Jan; 139(1):93-6. PubMed ID: 374639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased serum and pharyngeal antibody levels specific to streptococcal lipoteichoic acid in children with recurrent tonsillitis.
    Yokoyama Y; Harabuchi Y
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):199-207. PubMed ID: 11997155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
    Dale JB; Baird RW; Courtney HS; Hasty DL; Bronze MS
    J Infect Dis; 1994 Feb; 169(2):319-23. PubMed ID: 8106764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes.
    Ofek I; Simpson WA; Beachey EH
    J Bacteriol; 1982 Feb; 149(2):426-33. PubMed ID: 7035430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the periodate oxidation coupling method for the detection of antibody and antibody-producing cells specific for staphylococcal lipoteichoic acid.
    Beining PR; Flannery GM; Caldes G; Prescott B; Baker PJ
    J Immunol Methods; 1980; 32(2):167-76. PubMed ID: 6244350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human plasma fibronectin inhibits adherence of Streptococcus pyogenes to hexadecane.
    Courtney HS; Ofek I; Simpson WA; Whitnack E; Beachey EH
    Infect Immun; 1985 Jan; 47(1):341-3. PubMed ID: 3880729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular basis for the localization of bacterial infections.
    Christensen GD; Beachey EH
    Adv Intern Med; 1984; 30():79-112. PubMed ID: 6152109
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections.
    Wergeland H; Endresen C; Natås OB; Aasjord P; Oeding P
    Acta Pathol Microbiol Immunol Scand B; 1984 Oct; 92(5):265-9. PubMed ID: 6516850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.